THERAPEUTIC DRUG MONITORING DOSING REGIMEN WITH ADALIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE SERENE-UC MAINTENANCE STUDY
Jean-Frédéric Colombel 1
1 Icahn School of Medicine at Mount Sinai
Topic
IBD, Immunology, Surgery
Session
IBD Clinical I
Conference
UEG Week Virtual 2020
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
New to myUEG?
Social Sharing